Showing results (5021-5030 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|June 3, 2021
Patient-Reported Continuity of Care and Functional Safety Concerns After Inpatient Cancer RehabilitationJegy M Tennison, Amy H Ng, Nahid J Rianon, et al.The Oncologist|November 21, 2020
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study DesignJeffrey S Ross, Ethan S Sokol, Holger Moch, et al.The Oncologist|November 16, 2020
Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second-Line Treatment for Patients with Metastatic Colorectal CancerAlberto Sobrero, Heinz-Josef Lenz, Cathy Eng, et al.The Oncologist|January 4, 2021
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic ChallengesCristina Birzu, Suzanne Tran, Franck Bielle, et al.The Oncologist|January 5, 2021
Prioritization of Patients with Abnormal Breast Findings in the Alerta Rosa Navigation Program to Reduce Diagnostic DelaysJaime Tamez-Salazar, Teresa Mireles-Aguilar, Cynthia de la Garza-Ramos, et al.The Oncologist|January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II TrialHuabin Hu, Kun Wang, Meijin Huang, et al.The Oncologist|May 27, 2021
Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in TanzaniaSarah Kutika Nyagabona, Rohan Luhar, Jerry Ndumbalo, et al.The Oncologist|February 21, 2020
The Impact of Anlotinib on Brain Metastases of Non-Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)Shunjun Jiang, Hengrui Liang, Zhichao Liu, et al.The Oncologist|February 12, 2020
A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in JapanHirotoshi Iihara, Mototsugu Shimokawa, Toshinobu Hayashi, et al.Pageof 571